In the previous paper, 1 we described the novel cyclic hexapeptide antibiotic, NW-G01, produced by Streptomyces alboflavus 313. It is structurally related to himastatin 2, 3 and chloptosin, 4 including a chlorinated pyrroloindoline derivative, but is significantly different in the amino-acid content. In the further study of secondary metabolites of S. alboflavus 313, another novel cyclic hexapeptide NW-G03, a related structural compound of NW-G01, was discovered as a trace constituent from fermentation broth of this strain. The difference of chemical structure between NW-G03 and NW-G01 is only an aminoacid residue. The bioassay results showed that NW-G03 also showed strong antibacterial activity against gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA), but was ineffective against gram-negative bacteria. NW-G03 also inhibited the growth of three tumor cell lines in vitro.
In this paper, the isolation, structure elucidation, physicochemical properties and in vitro biological activity of compound NW-G03 are described.
NW-G03 was isolated from the fermentation broth of NW-G01-producing S. alboflavus 313, as a trace metabolite of interest. As described in our previous paper, 1 briefly, the supernatant (100 l) of the fermentation broth was adsorbed onto a macroporous resin (HPD400, Cangzhou Baoen, Hebei, China), followed by elution with methanol. The elution was evaporated to yield a residue (60 g). The residue was applied onto a silica gel column and eluted with EtOAc/MeOH (from 100:0 to 0:100). Then the antimicrobial fraction was purified by RP-HPLC (Hypersil C 18 , 20mmÂ250 mm, 10 mm) with methanol/water (75:25) as mobile phase to yield two new compounds NW-G01(168 mg) and NW-G03(11.2 mg). Unfortunately, satisfactory crystals of NW-G03 for X-ray anal could not be obtained.
The physicochemical properties of NW-G03 are summarized in Table 2 . At first, the molecular formula C 35 H 47 N 10 O 7 Cl was determined by HR ESI-MS (Table 1) . As the UV and 13 C and 1 H NMR spectra of NW-G03 were quite similar to those of NW-G01, the structure of which was determined by single crystal X-ray diffraction. 5, 6 The structure of NW-G03 (Figure 1 ) was elucidated by comparison with NW-G03, a related cyclic hexapeptide compound of NW-G01 Z Guo et al the 1 H and 13 C NMR data with those of NW-G01 ( 13 C NMR spectrum. The 13 C NMR (DEPT) spectrum showed 35 carbon signals, which were attributed to four methyl carbons, nine methylene carbons, eight methine carbons, three aromatic methine carbon, one sp 2 methine carbon, one oxygenated quaternary carbon, two quaternary carbons, one chloridated quaternary carbon and six carbonyl carbons by anal of the DEPT and HSQC spectra.
In the 1 H NMR spectrum, large coupling (J¼7. Figure 3 The MS/MS picture of NW-G03.
NW-G03, a related cyclic hexapeptide compound of NW-G01 Z Guo et al In comparison with NW-G01, the remaining residues of NW-G03 included two molecules of piperazic acid (PA) and a molecule of dehydrogenated PA. As only one remaining methenyl carbon (d 142.3) was present, a d-dehydro-piperazic acid was diagnosed easily.
To further verify the structural relationship between NW-G01 and NW-G03, The MS/MS experiments of NW-G01 and NW-G03 were carried out and the MS/MS pictures were showed in the Figures 2  and 3 , respectively. From the two MS/MS, some main fragment ion peaks were belonged and the fragmentations were determined in the Figures 4 and 5 . In the Figures 4 and 5 , the NW-G01 fragment ions (m/z 739, 672, 658 and 409) including PA were two more mass units than NW-G03 fragment ions (m/z 737, 670, 656 and 407) including PA, furthermore, the fragmentations of NW-G01 and NW-G03 contained the same fragment ion (m/z 533) without PA part. So, the above results also confirmed that the other structural parts of two compounds were completely uniform except the PA part (C¼N) of NW-G03.
The sequence linkage of the amino-acid residues in NW-G03 was established by the anal of HMBC data, which showed correlation from the a-methine protons of amino-acid residue to carbonyl carbon of the neighboring residues (Figure 1) .
The absolute configuration of the valine residues was determined by application of the Marfey's method using 1-fluoro-2,4-dinitrophenyl-5-L-alanineamide (FDAA) 3, 5, [7] [8] [9] and subsequent HPLC anal of the acid hydrolysate of NW-G03. The results of Marfey's anal revealed the presence of D-valine in the acid hydrolysate of NW-G03.
Antibacterial activity was measured by the micro-broth dilution method in 96-well culture plates by employing Mueller-Hinton broth (Hangzhou Microbial Reagent Co. Ltd), according to the Standard of National Committee for Clinical Laboratory (NCCLS). 10 The compound NW-G03 exhibited significant activity against several grampositive bacteria (Table 3) with MIC values of less than 25 mg ml À1 . No obvious inhibitory effects were observed against gram-negative bacteria at a concentration of 200 mg ml À1 . The tested gram-positive bacteria were Bacillus cereus 1.1846, Bacillus subtilis 1.88, S. aureus 1.89, MRSA 212 and the gram-negative bacteria were Escherichia coli 1.1636 and Pseudomonas aeruginosa 1.2031.
In addition, antitumor activities of NW-G03 against three human tumor cell lines were tentatively evaluated by the 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyltetrazolium bromide (MTT) method. [11] [12] [13] [14] [15] As summarized in Table 4 , the in vitro compound inhibited the growth of cell lines BEL-7402, HCT-116 and H460 in the concentration of 30 mg ml À1 .
In the isolation process of compound NW-G01, NW-G03, a trace constitutent showed antimicrobial activity was discovered. HR ESI-MS measurement exhibited that the molecular formula of NW-G03 only had two less hydrogen atoms than that of NW-G01. Furthermore, 1 HNMR and 13 CNMR spectral data revealed that these two compounds were highly similar skeleton structures except only one difference that NW-G03 contained a dehydrogenated PA moiety, whereas NW-G01 included a saturated PA moiety. Additionally, the valine residue of NW-G03 was also the D configuration by using Marfery's method, which agreed with the valine absolute configuration of NW-G01. 5, 6 The other residues configurations were confirmed in accordance with compound NW-G01, because the standard substances of these residues were not directly purchased. Therefore, compound NW-G03 is also structurally characterized as an octadeca-membered cyclic hexapeptide composed of D-valine moiety, N-methyl-D-alanine, PAs and a chlorined pyrroloindoline moiety and NW-G03 and NW-G01 were considered as a class of cyclic hexapeptide antibiotics.
In our current study, it was found that NW-G03 had higher antibacterial activities than ampicillin against B. cereus 1.1846, B. subtilis 1.88, S. aureus 1.89 and MRSA 212, especially to MRSA. It was homophilic with antibacterial spectrum of NW-G01, 1 himastatin 7 and chloptosin. 4 Surprisingly, NW-G03 was found to show strong activity against human hepatoma cell line BEL-7402, human colon cancer cell line HCT-116 and human large-cell lung carcinoma cell line H460 cultured in vitro. Further pharmacological studies and an investigation of the mechanism of action are now underway. NW-G03, a related cyclic hexapeptide compound of NW-G01 Z Guo et al
